Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs
2020-06-22 12:39
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
2020-06-01 08:45
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
2020-04-07 20:00
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma
2019-12-11 08:41
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
2019-11-25 07:00
Kazia Raises A$4.0 Million to Progress R&D Programs
2019-10-28 10:16
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer
2019-09-13 20:00
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
2019-09-12 21:10
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center
2019-07-22 09:08
Kazia calls for greater awareness of the deadliest brain cancer in the US
2019-07-17 20:00
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
2019-05-20 11:41
Kazia calls for greater awareness of the deadliest gynecological cancer in the US
2019-05-08 20:00
Kazia calls for greater awareness of the most lethal women's disease in Australia
2019-05-08 09:55
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference
2019-04-01 11:29
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting
2019-03-25 13:25
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million
2018-11-20 12:53
Progress Update on GDC-0084 Program
2018-10-29 18:00
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer
2018-10-22 18:00
Kazia Raises A$3.4 Million to Progress R&D Programs
2018-10-18 09:21
Cantrixil Phase I Study Progresses To Next Stage
2018-10-10 15:15
1
2
3
4